Dashboard
Manage Tickers

TYRATyra Biosciences, Inc.

Nasdaq tyra.bio


$ 14.47 $ -0.21 (-1.47 %)    

Wednesday, 17-Apr-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 426.06 $ -5.26 (-1.22 %)
DIA $ 377.52 $ -0.53 (-0.14 %)
SPY $ 500.59 $ -2.98 (-0.59 %)
TLT $ 89.29 $ 0.98 (1.11 %)
GLD $ 219.60 $ -1.63 (-0.74 %)
$ 14.45
$ 14.85
$ 0.00 x 0
$ 0.00 x 0
$ 14.40 - $ 14.85
$ 10.38 - $ 20.67
110,710
na
617.09M
$ 2.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-19-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-03-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wedbush-reiterates-outperform-on-tyra-biosciences-maintains-28-price-target
Wedbush Reiterates Outperform on Tyra Bios...
03/21/2024 12:47:22

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.

hc-wainwright--co-reiterates-buy-on-tyra-biosciences-raises-price-target-to-23
HC Wainwright & Co. Reiterates Buy on Tyra...
03/20/2024 10:42:45

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price ta...

tyra-biosciences-inc-files-for-resale-of-up-to-154m-shares-by-the-selling-securityholders
Tyra Biosciences Inc Files For Resale Of U...
03/19/2024 21:00:06

- SEC Filing

tyra-biosciences-q4-eps-053-misses-048-estimate
Tyra Biosciences Q4 EPS $(0.53) Misses $(0...
03/19/2024 20:12:19

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(...

sp-500-gains-over-1-amazon-earnings-top-expectations
S&P 500 Gains Over 1%; Amazon Earnings Top...
02/02/2024 19:32:50

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.8% on Friday. The Dow traded u...

why-skechers-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Skechers Shares Are Trading Lower By A...
02/02/2024 18:18:18

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarte...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
02/02/2024 17:31:03

nasdaq-rises-over-200-points-apple-posts-upbeat-earnings
Nasdaq Rises Over 200 Points; Apple Posts ...
02/02/2024 17:08:18

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Friday. The Dow traded ...

clorox-posts-upbeat-earnings-joins-cigna-deckers-outdoor-and-other-big-stocks-moving-higher-on-friday
Clorox Posts Upbeat Earnings, Joins Cigna,...
02/02/2024 15:35:13

U.S. stocks traded mixed, with the Dow Jones falling over 100 points on Friday.

tyra-biosciences-inc-announces-200m-private-placement-financing
Tyra Biosciences, Inc. Announces $200M Pri...
02/02/2024 13:06:21

tyra-biosciences-says-fda-granted-rare-pediatric-disease-designation-to-tyra-300-an-oral-fgfr3-selective-inhibitor-for-treatment-of-achondroplasia-the-most-common-form-of-dwarfism-with-limited-therapeutic-options
Tyra Biosciences Says FDA Granted Rare Ped...
02/01/2024 22:33:10

wedbush-reiterates-outperform-on-tyra-biosciences-maintains-27-price-target
Wedbush Reiterates Outperform on Tyra Bios...
12/29/2023 12:45:45

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $27 price target.

hc-wainwright--co-reiterates-buy-on-tyra-biosciences-maintains-19-price-target
HC Wainwright & Co. Reiterates Buy on Tyra...
12/26/2023 11:20:27

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $19 price...

tyra-biosciences-initiates-surf201-phase-1-study-and-doses-first-patient-with-tyra-200-co-also-received-fda-feedback-on-tyra-300-phase-2-ach-study-says-ind-submission-planned-for-2h-2024
Tyra Biosciences Initiates SURF201 Phase 1...
12/22/2023 14:01:39

chegg-perdoceo-education-and-other-big-stocks-moving-lower-on-monday
Chegg, Perdoceo Education And Other Big St...
11/20/2023 15:51:11

U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in t...

hc-wainwright--co-maintains-buy-on-tyra-biosciences-lowers-price-target-to-19
HC Wainwright & Co. Maintains Buy on Tyra ...
11/08/2023 13:09:44

HC Wainwright & Co. analyst Mitchell Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price tar...

tyra-biosciences-announces-oral-presentations-on-tyra-300-for-achondroplasia-at-the-asbmr-and-ashg-2023-annual-meetings
Tyra Biosciences Announces Oral Presentati...
09/21/2023 12:05:41

Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision me...

analyst-ratings-for-tyra-biosciences
Analyst Ratings for Tyra Biosciences
08/11/2023 15:00:30

wedbush-reiterates-outperform-on-tyra-biosciences-maintains-27-price-target
Wedbush Reiterates Outperform on Tyra Bios...
08/11/2023 14:41:11

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $27 price target.

hc-wainwright--co-maintains-buy-on-tyra-biosciences-raises-price-target-to-20
HC Wainwright & Co. Maintains Buy on Tyra ...
08/11/2023 11:51:13

HC Wainwright & Co. analyst Mitchell Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price tar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)